4
Changes in Ownership
KIORA PHARMACEUTICALS INC Filed Acc 0001372514-23-000149
Chief Development Officer acquired 62,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Daniels Eric Joseph Chief Development Officer | 2023-09-29 | Grant or award | +62,500 | 88,338 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Daniels Eric Joseph Chief Development Officer | 2023-09-29 | Grant or award · Stock Option (right to buy) | +125,000 | 125,000 | D: show line 2 in the form |
Loading xslF345X05/wk-form4_1696366080.xml…